IRVINE, Calif.–(BUSINESS WIRE)– #biologics–Immunis named a semifinalist for the National Academy of Medicine’s $1.5 million Healthy Longevity Grand Prize
IRVINE, Calif.–(BUSINESS WIRE)– #biologics–Immunis named a semifinalist for the National Academy of Medicine’s $1.5 million Healthy Longevity Grand Prize